Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Apr 8;397(10282):1350. doi: 10.1016/S0140-6736(21)00777-7

Department of Error

PMCID: PMC8054248  PMID: 33838756

The content is available as a PDF (127.1 KB).

Acknowledgments

Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 2020; 396: 1979–93—In figure 7 of this Article, the green line in the key should have been labelled “18–55 years group (low dose)”. This correction has been made to the online version as of April 8, 2021.


Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES